Bruker is a performace leader in preclinical imaging instrumentation. Bruker offers nine imaging modalities: PET, SPECT, CT, MRI, MPI, fluorescence, luminiscence, radioisotipic imaging and X-ray.
Discover
Back to filter
Show all topics (10)
Related topics
Extensive assessment of Cytokine production on the NovoCyte Penteon flow cytometer
Nov 29, 2021
Cytokines are small molecules essential for immune cell response to activation by pathogens, autoimmunity, or...
Accelerating AML Research Through Single-cell Multi-omics- integrate seamlessly into existing NGS
Nov 25, 2021
Dr. Linde Miles Memorial Sloan Kettering Cancer Center about her research, use of the Tapestri as a single-cell...
Discover the advanced Detector Technology in Agilent NovoCyte flow cytometers
Nov 18, 2021
This technical overview describes advancements in detector technology, and highlights examples where optimal signal...
WEBINAR: Recent Advancements In Neurodegenerative Biomarkers
Sep 6, 2021
Recent Advancements in Neurodegenerative Biomarkers: Progress Towards a Diagnostic Blood Test for Alzheimer’s Disease
How to Improve Your Viral Nucleic Acid Extraction Processes
Sep 6, 2021
High-Throughput Extraction with CyBio FeliX
Introducing New Aura 4.0 software
Aug 31, 2021
With new features for both acquisition & analysis Aura Software enables you to capture and analyze your data quickly,...
Comparison of gamma and x-ray irradiation results
Aug 12, 2021
Biological effects of Cs-137 and X-ray irradiators are comparable with regards to...
Hypoxia further exacerbates myopathy in broilers via alteration of satellite cell fate
Aug 2, 2021
Woody breast (WB) condition has created a variety of challenges for the global poultry...
High quality Bioluminescence and X-Ray analysis in lung squamous cell carcinoma
Jul 21, 2021
Spectral Instruments Imaging provides unrivaled sensitivity for bioluminescence,...
Top 10 Pharma companies have chosen CYTEK for their flow cytometry facility
Jul 15, 2021
6 of Top 10 Pharma Companies (Based on total group revenues) have chosen CYTEK - full...
Analysis of bone parameters denoting skeletal impairment in a mouse model
Oct 23, 2017
In this application note, scientific team detail how the planar X-ray image and the Bruker Molecular Imaging Bone Density Software module can be used to quantify changes in bone parameters in genetically modified animal models. The software module enables the measurement of linear bone parameters, e.g. length and width, as well as bone mineral and bone surface density. Bone density is an important biomarker in health sciences to discriminate healthy bones from diseased ones and often used in in vivo microCT analysis. Thus, it is widely applied in monitoring diseases such as osteoporosis, arthritis and other musculoskeletal disorders. With the availability of genetically modified animals, the impact of genes of interest on skeletal development can be monitored relatively easily and economically with systems such as the Bruker In-Vivo FX PRO or In-Vivo Xtreme.
Related technologies: Fluorescence, luminescence, X-ray, radiographic imaging
Brand profile
